Infectious Diseases and Preferred Treatments (Status: Incomplete)
Table 29-5. Treatment of Tuberculosis |
||
Disease stage |
Treatment |
Duration |
Latent (probably isoniazid sensitive) |
Isoniazid |
9 months (6 months possible except for children and HIV-positive persons) |
Latent (probably isoniazid resistant) |
Rifampin + apyrazinamide |
2 months |
Active disease |
Isoniazid + rifampin + pyrazinamide |
2-4 months |
Table 29-1. Empiric Treatment of Meningitis |
||
Age of patient |
Most likely organism |
Empiric treatment |
Newborn to 1 month |
Gram-negative enterics (Escherichia coli), group B streptococci, or Listeria monocytogenes |
Ampicillin and aminoglycoside, cefotaxime, or Ceftriaxone |
1 month to 4 years |
Haemophilus influenzae, Neisseria meningitidis, or Streptococcus pneumoniae |
Cefotaxime or ceftriaxone, plus vancomycin |
5-29 years |
N. meningitidis, S. pneumoniae, or H. influenzae |
Cefotaxime or ceftriaxone, plus vancomycin |
30-60 years |
S. pneumoniae or N. meningitidis |
Cefotaxime or ceftriaxone, plus vancomycin |
> 60 years |
S. pneumoniae, Gram-negative enterics (E. coli), or L. monocytogenes |
Cefotaxime, ceftriaxone, or ampicillin and aminoglycoside-vancomycin |
NOTES:
ü Empiric therapy hallmarkà coverage of the most common pathogen associated with the infection
ü Most cellulitis infections are associated with Staphylococcus aureus and Streptococcus pyogenes.
ü Cant be cultured in cell media
o Rickettsia rickettsii.
o Ehrlichia phagocytophila.
o Francisella tularensis.
ü Staphylococcus and Bacillus diarrheas are an intoxication not caused by a living organism. Both Salmonella and E. coli diarrheas should be treated only if severe or if signs of systemic infection are present. Vibrio cholerae causes a severe diarrhea requiring anti-infective treatment.
ü P.carinii as many HIV patients (Oppurtunistic infections)
ü Most common organisms associated with COMMUNITY ACQUIRED PNEUMONIA IN ADULTS
o Chlamydia pneumoniae is not a pathogen associated with adult pneumonia.
o Answer: Mycoplasma pneumoniae, Streptococcus pneumoniae, and Haemophilus influenzae.
|
|
|
|
Gonorrhea Syphilis |
Neisseria gonorrheae Treponema pallidum- cannot grown in culture, dark field fluorescent antibody exam VDRL test Rapid plasma regain test (RPR Gonorrhea- Gram negative; gram stain) |
Penicillin |
|
Tick borne Systemic Febrile Syndromes |
|||
Lyme disease
|
Borrelia burgforfei |
Doxycycline |
|
Rocky mountain spotted fever |
Rickettsia rickettsii |
||
Ehrlichiosis |
Erlichia phagocytophila |
||
Tularemia |
Francisella tularensis |
Gentamicin tobramycin |
|
Hepatitis |
|||
Hepa B |
Chronic |
Interferon alfa 2b Lamivudine |
|
Hepa C |
Chronic |
INF alfa 2b RIBAVIRIN |
|
Hepa C |
Acute |
INF a2b |
|
Influenza |
|||
Influenza A |
|
Oseltamivir -mivir Rimantadine |
|
Influenza B |
Prohylaxis |
Oseltamivir |
|
Herpes Virus |
|||
Herpes Simplex |
Initial |
Acyclovir |
|
Recurrence |
Famciclovir |
||
Chronic suppresion |
Valacyclovir |
||
Immunocompromised |
Acyclovir |
||
Resistance to Acyclovir |
FOSCARNET |
||
Varicella zoster |
|
Acyclovir/ Foscarnet |
|
UTI |
|||
Cystitis Pylonephritis Prostatitis |
|
QUINOLONE TMP-SMX |
|
|
|
|
|
Endocarditis |
|
Penicillins allergic: vancomycin |
|
Hospital acquired pneumonia |
|
aminoglycoside and one other Gram-negative agent, such as cefepime. :MRSA vancomycin |
|
Prostate infections |
4-6 weeks |
CIPROFLOXACIN: concentrate in prostate fluid TMP-SMX reasonable chice |
|
Candida infections |
|
Amphotericin and Fluconazole |
|
0 comments: